S. Eckhardt, “Recent Progress in the Development of Anticancer Agents,” Current Medicinal Chemistry Anti-cancer Agents, Vol. 2, No. 3, 2002, pp. 419-423. doi:10.2174/1568011024606389

has been cited by the following article:

• TITLE: (Z)-N-(3-(2-Chloro-4-nitrophenyl)-4-methylthiazol-2(3H)-ylidene) Pivalamide: Synthesis and Crystal Structure

  AUTHORS: Aamer Saeed, Michael Bolte

  KEYWORDS: Synthesis, 1-Pivaloyl-3-(2-chloro-4-nitrophenyl) Thiourea, (Z)-N-(3-(2-Chloro-4-nitrophenyl)-4-methylthiazol-2(3H)-ylidene) Pivalamide, Crystal Structure

  JOURNAL NAME: Journal of Crystallization Process and Technology, Vol.1 No.3, October 13, 2011

  ABSTRACT: Synthesis of the title compound was carried out by base-catalyzed cyclization of 1-pivaloyl-3-(2-chloro-4-nitrophenyl) thiourea with α-bromoacetone produced in situ. The structure was confirmed by the spectroscopic and elemental analysis and single crystal X-ray diffraction data. It crystallizes in the triclinic space group P-1 with unit cell dime sions a = 8.7137(10), b = 10.2010(14), c = 10.6593(13), α = 62.671(9), β = 82.701(10), γ = 79.762(10), V = 827.21(8) ų, Z = 2.